HIV and AIDS Trial, Recruiting (NCT06857071)

HIV and AIDS Trial, Recruiting NCT06857071 Sponsor: University of Illinois at Chicago Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT06857071 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been given an official recruitment coupon — either by a clinic taking part in the study, or by another person already participating in the trial
People who are 18 years old or older
People who are able to take part in an interview conducted in English or isiZulu
People who are able to give informed consent to participate in the study
People who currently live in the Msunduzi region of KwaZulu-Natal, South Africa

Who may not be able to join:

People who do not have an official recruitment coupon from a participating clinic or from a current trial participant
People who are under 18 years old
People who are not able to be interviewed in English or isiZulu
People who are not able to give informed consent
People who do not live in the Msunduzi region of KwaZulu-Natal, South Africa

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 12 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Leslie D. Williams, Ph.D., University of Illinois at Chicago

Phone: 312-996-8820

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06857071

Sponsor: University of Illinois at Chicago

Phase: Not Applicable

Status: Recruiting

Condition: HIV and AIDS

Trial contact: 312-996-8820

More information: https://clinicaltrials.gov/study/NCT06857071

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been given an official recruitment coupon — either by a clinic taking part in the study, or by another person already participating in the trial
People who are 18 years old or older
People who are able to take part in an interview conducted in English or isiZulu
People who are able to give informed consent to participate in the study
People who currently live in the Msunduzi region of KwaZulu-Natal, South Africa

Who may not be able to join:

People who do not have an official recruitment coupon from a participating clinic or from a current trial participant
People who are under 18 years old
People who are not able to be interviewed in English or isiZulu
People who are not able to give informed consent
People who do not live in the Msunduzi region of KwaZulu-Natal, South Africa

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 12 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Illinois at Chicago

Registry

ClinicalTrials.gov

Start date

30 September 2025

Est. completion

1 December 2027

Where this trial is recruiting

🇿🇦 South Africa

Primary endpoints

Rates of men recruited to HIV testing; Rates of people newly-diagnosed with HIV by the intervention (i.e., people with previously-undiagnosed HIV infection); Individual-level experiences of HIV-related stigma; Individual-level enacted HIV-related stigma (measured using HIV Stigma Scale); Social experiences related to participation in the study; Community-level HIV-related stigma

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov